What sector does GC Medical Science Corporation belong to?

GC Medical Science Corporation operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 142280?

As of the latest available quote, 142280 traded at ₩3,105.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 142280?

GC Medical Science Corporation has a price-to-earnings (P/E) ratio of about 18.37. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 142280?

The market capitalisation of GC Medical Science Corporation is approximately ₩63.59B.

Is GC Medical Science Corporation profitable?

For its latest reported financial year, GC Medical Science Corporation recorded a net profit margin of about 3.19%.

What is the return on equity (ROE) of 142280?

GC Medical Science Corporation has a return on equity (ROE) of about 8.26%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 142280?

Over the past 52 weeks, 142280 has traded between a low of ₩2,200.00 and a high of ₩6,660.00.

GC Medical Science Corporation

142280 KRX Pharmaceuticals Pharmaceuticals

KOSDAQ

₩3,105.00

+0.16%

Delayed · cached 15 min

Fair value analysis

142280

GC Medical Science Corporation

₩3,105.00

Close used for this calculation

₩2,372.86Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

32/100

Profitability4/25

Returns5/25

Balance Sheet12/25

Efficiency11/25

Growth0/25

Weak

Quality radar

Consensus fair value

₩2,372.86

Above FV

▼ -23.6% against the close used

Model range ₩1,409.82 – ₩3,380.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,409.82Fair value₩2,372.86Bull₩3,380.00

FairClose

52-week traded range

52W low ₩2,395.0052W high ₩3,215.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

GC Medical Science Corporation closed at ₩3,105.00, 30.9% above the consensus fair value of ₩2,372.86 drawn from 7 valuation models.

Financial DNA score 32/100 — Weak. P/E of 18.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩2,265.60

-27.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩2,787.04

-10.2%

√(22.5 × EPS × BVPS)

EPS=169, BVPS=2042.76 · outside Graham range (P/E 18.4, P/B 1.5) — asset-light, treat as a rough floor

P/E Fair Value

₩3,380.00

+8.9%

EPS × 20x (sector P/E)

EPS=169, Sector P/E=20x

EV/EBITDA

₩1,409.82

-54.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=2.89B

Book Value (P/B)

₩1,534.99

-50.6%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=2042.76, ROE=8.3%, g=3%, r=10%

Reverse DCF

₩3,105.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 6% | Historical: 0%

Margin of Safety

₩2,108.16

-32.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=2810.88, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer